ANDRES VALDIVIESO LOPEZ-rekin lankidetzan egindako argitalpenak (4)

2013

  1. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: Pharmacokinetic considerations and patient pathophysiology

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 51, Núm. 7, pp. 606-614

  2. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction

    European Journal of Clinical Pharmacology, Vol. 69, Núm. 1, pp. 65-74

2011

  1. Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation

    European Journal of Clinical Pharmacology, Vol. 67, Núm. 7, pp. 671-679

2008

  1. ROLE OF TOTAL AND UNBOUND PLASMA CONCENTRATIONS OF TACROLIMUS IN CLINICAL OUTCOME

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY